Akebia Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 First Street, Cambridge, MA

Insiders trading volume in the past year

Akebia Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John P. Butler CEO and President, Director $3.74M -$209K -5.3% Feb 29, 2024
Steven K. Burke SVP, Chief Medical Officer $1.1M -$64.9K -5.57% Feb 29, 2024
Ellen Snow SVP, CFO and Treasurer $872K Jan 31, 2024
Michel Dahan SVP, Chief Operating Officer $847K -$73.9K -8.03% May 13, 2024
Nicole R. Hadas SVP, Chief Legal Officer $821K -$35.8K -4.19% May 13, 2024
David A. Spellman SVP, CFO and Treasurer $546K May 16, 2023
Nicholas Grund Chief Commercial Officer $510K Jan 31, 2024
Erik Ostrowski SVP, CFO, CBO & Treasurer $441K Jun 28, 2024
Richard C. Malabre Chief Accounting Officer $376K Jan 31, 2024
Violetta Cotreau SVP, Chief Accounting Officer $269K May 12, 2022
Dell Faulkingham Svp, Cco $213K Feb 28, 2022
Adrian Adams Director $208K Jun 6, 2024
Michael W. Rogers Director $159K Jun 6, 2024
Cynthia Smith Director $158K Jun 6, 2024
Steven Gilman Director $148K Jun 6, 2024
Myles Wolf Director $123K Jun 6, 2024
Leanne M. Zumwalt Director $92.9K Jun 6, 2024
Ron Frieson Director $92.9K Jun 6, 2024
Michael Thomas Heffernan Director $59.4K Jun 2, 2021

Recent Insider Transactions by Companies or Individuals for Akebia Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.